ãã¯ãªã¹ãã£ã³ãã¥ã㣠Twitterçžäºãã©ããŒãæ§ãã
ã·ã§ã¢ãæ²èŒã
ããããšãããããŸãã
æè¬ã§ãã
人工ç¥èœïŒïŒ¡ïŒ©ïŒåéšãããã¹ãé£çïŒïŒ³ïŒ¢ïŒ£ïŒã¢ã¡ãªã«ã©ãã»ã«ã»ã ãŒã¢
ãæäŒãã«å¯Ÿããç©æ¥µçãªåãçµã¿ãããç±³åéšãããã¹ãé£çã声æ
2019幎5æ2æ¥12æ48å
ç±³ãããã¹ã¿ã³ãæ倧æ掟ã§ããåéšãããã¹ãé£çïŒïŒ³ïŒ¢ïŒ£ïŒã®å«çå®æèªç±å§å¡äŒïŒïŒ¥ïŒ²ïŒ¬ïŒ£ïŒããã®ã»ã©ã人工ç¥èœïŒïŒ¡ïŒ©ïŒãäž»èŠããŒãã«ãã声æïŒè±èªïŒãçºè¡šããã声æã¯ãæå 端æè¡ãæèµ·ããå®åçãã€ç¥åŠçåé¡ã«è§ŠããæäŒãã«åãçµãå¿ èŠæ§ããããšããèãã瀺ããã
声æã¯ããšäººéã®é¢ä¿ã«é¢ããåºæ¬çãªå 容ããããå»çããã»ã¯ã·ã¥ã¢ãªãã£ãŒããããŒã¿ãšãã©ã€ãã·ãŒããå®å šä¿éããæŠäºããªã©ãèšïŒïŒé ç®ã«ãããããŒããæ±ã£ãŠãããããããèãã®åºãšãªãèæžç®æãšå ±ã«çŠé³çãªèŠ³ç¹ãã觊ããããŠããã
åºæã«ã¯æ¬¡ã®ããã«æžãããŠããã
ãã¯ãªã¹ãã£ã³ã¯æªæ¥ãæè¡ã®çºå±ãæããŠã¯ãªããŸããããªããªãç§ãã¡ã¯ãç¥ãæŽå²ã統治ããŠããããããšãç¥ã£ãŠãããç¥ã®ããã¡ã«é ããã人éã«åã£ãŠä»£ãããã®ã¯äœäžã€ãªãããšãç¥ã£ãŠããããã§ããç§ãã¡ã¯ãããããŸã§ã«ãªãå¯èœæ§ã人é¡ã«ããããããšãèªèããŠããŸããããããã®äžæ¹ã§ãç¥æµãé æ ®ãªãããŠïŒ¡ïŒ©ã䜿çšããå Žåãããã«ãã£ãŠåŒãèµ·ããããæœåšçãªã¹ã¯ãããããšãèªèããŠããŸãã
ç§ãã¡ã®é¡ãã¯ãæäŒãã®åéã«ç©æ¥µçã«åãçµããããåããããããšã§ããæœåšçãªåé¡ãè«žæäŒã«åœ±é¿ãåãŒããŠããŸã£ãåŸã§ããããã®åé¡ã«å¯Ÿå¿ããŠãããããšã§ã¯ãããŸããã
声æã«ã¯ãã§ã«ãããªã¹ãæ倧åŠã®åŠé·ãç¥åŠæ ¡ã®æ ¡é·ã倧åæäŒã®ç§åž«ãããªã¹ãæå£äœã®æå°è ãã眲åããŠãããäž»ãªçœ²åè ã«ã¯ãä¿å®æŽŸè«å®¢ãšããŠç¥ããããšãªãã¯ã»ãšãªã¯ãœã³æ°ããç±³ä¿å®æŽŸããªã¹ãæå£äœããã©ãŒã«ã¹ã»ãªã³ã»ã¶ã»ãã¡ããªãŒãã®ãžã ã»ããªãŒäŒé·ãç±³çŠé³æŽŸèªãã¯ãªã¹ãã£ããã£ãŒã»ãã¥ãã€ãã®ããŒã¯ã»ïŒªã»ã¬ãªãŒç·šéé·ãç±³ãªããã£ãŒå€§åŠã®ã«ã¬ã³ã»ã¹ã¯ããŒã»ãã©ã€ã¢ãŒææããããã
ã®ã¯ãªãšã€ãã£ããã£ã¬ã¯ã¿ãŒã§ãçŸåšïŒ¡ïŒ©ã«é¢ããèæžãå·çäžã®ãžã§ã€ãœã³ã»ãµãã«ãŒæ°ã¯ãäžæ©ã声æã«ã€ããŠè§Šããã¯äººéã®ç¹æ ã«åœ¹ç«ã€å¯èœæ§ããããã人éã®å°å³ã«å¯Ÿããè åšã®æ倧ã®åå ã®äžã€ã«ããªãåŸããšè¿°ã¹ãã
ãïŒãã¯ãããžãŒã®ããŒã«ã§ããïŒããèªäœã¯ãèæžã®ãããªãç®æã§ããéªæªã ãšãæªããšããéé£ãããŠããŸãããéªæªã§çœªæ·±ããå£ããŠããã®ã¯äººéã®æ¹ã§ãã
æè¡ã®éçºã¯è¯ãããšãããããªãããã ããã®æ¡ä»¶ã¯ãäžäººäžäººã®äººéãç¥ã®ããã¡ã«é ãããŠãããšããç解ã«åºã¥ããŠãããæè¡ãç¥ã«æ å ãåž°ããããé£äººãæãããããããã«çšããããããšã ãšãµãã«ãŒæ°ã¯åŒ·èª¿ããã
ã®ã©ãã»ã«ã»ã ãŒã¢å§å¡é·ã¯ã声æã®çºè¡šåŸã«è¡ãããã¯ãªã¹ãã£ã³ãã¹ããšã®ã€ã³ã¿ãã¥ãŒã§æ¬¡ã®ããã«è¿°ã¹ãã
ãç§ãã¡ã«å¿ èŠãªã®ã¯ãèæžçãªæèãæã€ã¯ãªã¹ãã£ã³ããããããåé¡ã«åãçµãããšã§ããã¯ãªã¹ãã£ã³ãããããåé¡ã«åãçµãŸãªããªããå¥ã®äººãå¥ã®äžç芳ã§ãã®ç©ºæŽãæºãããŠããŸãã§ãããã
ã ãŒã¢æ°ã¯ãŸãããšãè¶ äººé䞻矩ïŒå é²çç§åŠæè¡ã«ãã£ãŠäººéã®èº«äœæ©èœãé²åãããããšïŒãæçœãªå人éçã€ããªãã®ãŒããçããè«žåé¡ãæ··åãããåŸåã«ã€ããŠã次ã®ããã«çããã
ãæè¡ç£æ¥ã®äººãã¡ã®ã³ãã¥ããã£ãŒã¯ãæäŒã®äº€ãããåŒååã®åããå±ããªããšããã«ãããšæããŸããç§ã¯ãæè¡æ¥çã«ããã¯ãªã¹ãã£ã³ããå€ç¬ã ãšãã話ãèããŸãã人éé¢ä¿ã®äžã§å€ç¬ã ãšããã ãã§ã¯ãªãã圌ããåãçµããããžã§ã¯ãã«ãããŠæèããããã®è¯å¿ã圢æãããšããç¹ã«ãããŠãå€ç¬ã ãšããã®ã§ãããªãããšãããšãæè¡æ¥çã®ã¯ãªã¹ãã£ã³ã¯ä»ã®ã¯ãªã¹ãã£ã³ãšã®æ¥ç¹ãæããªãããã§ãã
ãç¹å®ã®åéã§æãããææ¡ããããŠããããšã«æ°ä»ããšããç§ãã¡ã¯ãããããã®åéã«ããæ·±ãåãçµãããã®åºæ¿ã«ãã¹ãã§ãã
声æã®ç¬¬ïŒé ãç¥ã®ããã¡ãã§ã¯ã次ã®ããã«è¿°ã¹ãããŠããã
ãããããã¯æ¬¡ã®ããšãåŠå®ããã被é ç©ã®äžéšåãããããã圢æ ã®æè¡ãå«ããç¥ã人é¡ã«ã®ã¿å§ããæ¯é ã管çã®æš©éã奪ã£ãããããã«åã£ãŠä»£ããããã«äœ¿çšãããããšãããŸãæè¡ã«å¯Ÿããäžå®ã®ã¬ãã«ã®äººéã®ã¢ã€ãã³ãã£ãã£ãŒã䟡å€ãå°å³ããŸãã¯é埳çå€æåãå²ãåœãŠãããããšãã
ã ãŒã¢æ°ã¯ãæèèªäœãæ©æ¢°ã«ãã£ãŠãåçŸããåŸããšããè¶ äººé䞻矩ã®åºæ¬çãªåæã«ã¯æ¬ é¥ããããšè©±ãã
ãç§ã¯ããïŒè¶ 人é䞻矩ïŒã¯å¿é ããŠããŸãããç§ãå¿é ããŠããã®ã¯æ¡åŒµçŸå®ïŒäººãç¥èŠããçŸå®ç°å¢ãã³ã³ãã¥ãŒã¿ã«ããæ¡åŒµããæè¡ïŒãã»ãã¯ã¹ã»ãããããªã©ã®ããŸããŸãªæè¡ã§ããããããã«é¢ããçåãæŸçœ®ãããŠããããšã§ãã
ïŒïŒå¹Žåãç¥åŠæ ¡ã§æéãå·ã£ãŠããã ãŒã¢æ°ã¯ãææ«è©Šéšã§ç¥åŠçãã¡ã«å°ããããã©ã³ã¹ãžã§ã³ããŒã ãšè©±ã人ãšçŠé³ãåãã¡åãã«ã¯ã©ããã¹ãããšã
ãæ宀ã«ããåŠçã®ã»ãšãã©ããããã¯éè®ã§ä»®æ³çãªã²ã£ããåé¡ã ãšèããŸããããšã ãŒã¢æ°ããããã§ç§ã¯èšããŸãããããããããªãããåãã¡å šå¡ãããã®åé¡ã«åãçµãããšã«ãªããã ããšã
é·è掟ã®ç§åž«ã§ãéå¶å©å£äœãã³ã¯ãªãšã€ã¿ãŒãºããã¯ãã®åµèšè ã§ããã¯ãªã¹ããã¡ãŒã»ãããã¯æ°ã¯ãã®å£°æã称è³ãããããã¯çŸåšã®ãšãããã«é¢ããåé¡ã«åãçµãããšããæå£ãã»ãšãã©ãªãããã ã
ãäŸãã°ãç§ãæå±ããã¢ã¡ãªã«åè¡åœé·èæäŒïŒïŒ°ïŒ£ïŒïŒµïŒ³ïŒ¡ïŒã¯ããšèªååã®åé¡ãåã«ç 究ãããšããè°æ¡ã§ããæšå¹Žã®å€ãã»ã³ãã«ã€ã¹ã§éãããç·äŒã§åŠæ±ºããŸãããã§ãããç§ã¯ãå€ãã®é²æ©äž»çŸ©ã®æäŒãããŸã ã«åãçµãã§ããªãé åããçŠé³æŽŸã®æäŒãç©æ¥µçã«åãçµãããšãããããæã£ãŠããŸãã
ããããããã¯æ°ã¯ãä»åã®å£°æã¯ãçŸåšå¿ èŠãšãããŠããäºæã®åæ©çãªå 容ãç¹°ãè¿ãè¿°ã¹ãŠããã«éãããæè¡è ããã®æèŠãæ¬ ããŠããã幟ã€ãã®ããŒãã«ã€ããŠè¿èŠçŒçã§ãããšèããŠããã
ãäŸãã°ãèªååã«é¢ããŠã¯ãããã³ãŒãŒã»ã¢ã³ãã»ã«ã³ãããŒã«ãããã®åé¡ã«é¢ããäžçã§æãåªããå ±åã§ãèªååã«ãã倱æ¥çã¯ïŒïŒïŒïŒå¹ŽãŸã§ã«ïŒïŒïœïŒïŒããŒã»ã³ãã«ãªããšäºæ³ãããŠããŸããã¡ãªã¿ã«ã倧ææ äžã®å€±æ¥çã¯ïŒïŒããŒã»ã³ãã§ãããç±³åœã®ïŒïŒããŒã»ã³ãã®æäŒã§ãæäŒå¡æ°ãïŒïŒïŒäººãäžåã£ãŠããããããã®æäŒã®å€ããç§åž«ãéãããšã«èŠåŽããŠããŸããç®éãïŒïŒããŒã»ã³ãæžå°ããããšã¯ãïŒïŒå¹ŽåŸã«ç±³åœã®æäŒæ°ãåæžãããããŸããããšãããã¯æ°ã¯æãã
ããšããªã¹ãæçå šè¬ããããåœé¢ã®åé¡ã§ã¯ãªããšèããŠãããªããç§ãã¡ã¯ããã°ããããé§åã®ããŒããèŠéããŠããã®ã§ããéèŠãªåé¡ã¯æ¬¡ã®éãã§ããå°æ¥çã«ç€ŸäŒãæäŒãæãå¿ èŠãšãããšããç§ãã¡ã«ã¯å©ããçšæãããã§ããããããããšãããããã»ã©ãããªãæäŒã®æš©åã®ããã«ãç¥åŠçãªèŠããããç¶ããã®ã§ãããããç§ã®ç¥ãã¯ãããªã¹ããæããéããæäŒå šäœãä»ã®äººãã¡ãå©ããçšæãã§ããŠããããã«ããšãããã®ã§ãã
â»ãã®èšäºã¯ã¯ãªã¹ãã£ã³ãã¹ãã®èšäºãæ¥æ¬åãã«ç¿»èš³ã»ç·šéãããã®ã§ããäžéšãå çã»çç¥ãªã©ãå€æŽããŠããéšåããããŸãã
ç¶ããŠ
ãAlzhacker/ã¢ã«ãããã«ãŒ.ãæ§ãã
ã·ã§ã¢ãæ²èŒã
ããããšãããããŸãã
æè¬ã§ãã
ã¬ã€ã»ã«ãŒãã¯ã€ã«ãæã£ãŠãããµããªã¡ã³ããšãã®çç±ã¯ïŒ
2022.02.06
2018幎7æ20æ¥ããã©ã³ã»ã³ãã»ãã³ã°ãŽã§ã€ãã£
ãæ³åã®ãšãããã¬ã€ã»ã«ãŒãã¯ã€ã«ã¯ã圌ã®ãµããªã¡ã³ãäœå¶ã«ã€ããŠãã質åãããããã®è³ªåã¯ã ããã次ã®ãããªãã®ã§ããããã¬ã€ã1æ¥ã«250åã®é å€ã飲ãã§ãããšããã®ã¯æ¬åœã ãããïŒããç¶ããŠãã·ã³ã®ã¥ã©ãªãã£ã«åããŠå¥åº·ã§è¥ã ããããããã«äœã飲ãã§ãããïŒããšãã質åã§ããã
ãã©ã€ãã·ãŒãžã®é æ ®ãšãå人ã®ããŒãºã倧ããç°ãªãããšãããã¬ã€ã¯äœå¹Žãèªåã®çããèžã«ããŸã£ãŠãããæã ãç¥ãããšãã§ããã®ã¯ã圌ã®èæžãFantastic VoyageããšãTranscendãããã§ãã£ããæè¿ã«ãªã£ãŠãã¬ã€ã¯å¿ãéããŠã圌ã®ãµããªã¡ã³ãçæ³ãã©ã€ãã¹ã¿ã€ã«ã®éžæã«é¢ããå人çãªæ å ±ãæäŸããããã«ã¯ã€ã³ã¿ãã¥ãŒã®ããã«åœŒã®å®å®¶ã§ã®æ®åœ±ãèš±å¯ããããã®ææã®ã€ã³ã¿ãã¥ãŒãã芧ã«ãªã£ãæ¹ã¯ãã¬ã€ãéžãã ããã3ã®ãµããªã¡ã³ãããã¹ãã¡ããžã«ã³ãªã³ãã¬ã¹ãã©ãããŒã«ããŠããããŒã«ã«ã€ããŠèªã£ãŠããã®ãèããããšããããšæãããã®3ã€ã®ãµããªã¡ã³ãã¯ãåœç€Ÿã®ã¢ã³ããšã€ãžã³ã°ãã«ãããã¯ãã¯ãããåœç€Ÿã®ãŠã§ããµã€ãã«ãæ²èŒãããŠãããããã®ä»ã«ãã¬ã€ãèæžã§çŽ¹ä»ããŠããæ°å€ãã®ãµããªã¡ã³ããããã
ã§ã¯ãã«ãŒãã¯ã€ã«ãæ¯æ¥é£²ãã§ãã97çš®é¡ã®è¬ã¯ã©ããªã£ãŠããã®ã ãããïŒãããç¥ãããã ããã
ãŸãã以äžã®3ã€ã®ãµããªã¡ã³ãã«ã€ããŠèª¬æããã
ã¬ã¹ãã©ãããŒã«ïŒResveratrolïŒ
ããŒããããããªãŒé¡ããããŠã®ç®ãªã©ã«å«ãŸããååç©ã§ãæé žåäœçšãããããããå¿èç ãªã©ã®å 霢æ§çŸæ£ãäºé²ãããšè©±é¡ã«ãªã£ãŠããã
ãã¹ãã¡ããžã«ã³ãªã³ïŒPCïŒ
å 霢ãšãšãã«å€§ããæžå°ãããã®æ é€çŽ ã¯ã现èã¬ãã«ã§ã®èåã«å¯Ÿæããããã®ãããæ é€çŽ ã®äžã€ã§ããã现èèã®æè»æ§ãä¿ã¡ããæ¹ã«ãå§ãã§ããïŒ1æ¥2åïŒã
ãŠããããŒã«
ãŠããããŒã«ã¯ã现èã«ãšãã«ã®ãŒãäŸçµŠããã®ã«äžå¯æ¬ ãªã³ãšã³ã¶ã€ã Q10ã®æŽ»æ§åãã圢ã§ãããç 究ã«ãããšããŠããããŒã«ã¯ããŠã¹ã®èåãé ãããããéåã«ããç²åŽã軜æžããå¹æããããšãããŠããã(1æ¥2ç²ïŒ100mgïŒã®å Žå
ãã®3ã€ã®ãµããªã¡ã³ã以å€ã«ããã¬ã€ã¯å»åž«ã®å³éãªç®¡çã®ããšã1æ¥100ç²ã®ãµããªã¡ã³ããæåããé±1åã®éè泚å°ãè¡ã£ãŠããã以äžã§ã¯ãã¬ã€ã®äœå¶ãã«ããŽãªãŒå¥ã«çŽ¹ä»ããã
åèãŸã§ã«
ãµããªã¡ã³ããæåããéã¯ãå¿ ãå»åž«ã«çžè«ããããšããå§ãããããŸããå人ã®ããŒãºãç®æšã«åãããŠæåããããšã倧åã§ãããéæ³ã®è¬ã¯ãªããã ãããããã¬ã€ãšããªãŒã¯ãäžäººã²ãšãã®ããŒãºãç¶æ³ã«å¿ããŠãååãªæ å ±ãåŸãäžã§éžæããããšã®éèŠæ§ã蚎ãç¶ããŠããã®ã§ãããããã§ã¯ãæ©é玹ä»ãããã
æççå€
ã¯ã«ã¯ãã³
ã¯ã«ã¯ãã³ã¯ããŠã³ã³ã®äž»ãªæå¹æåã§ããã
匷åãªæççäœçšããããéåžžã«åŒ·ãæé žåç©è³ªã§ãããã
EPA/DHAïŒãªã¡ã¬3ç³»éæ²¹ïŒ
äž»ã«æ€ç©æ§ã®æ²¹ã«å«ãŸãããªã¡ã¬6ç³»èèªãšãéãã¯ã«ããäºéº»ä»ãªã©ã«å«ãŸãããªã¡ã¬3ç³»èèªãšãã2ã€ã®äžé£œåèèªã®ãã¡ããªãŒãã100幎åã«ã¯æ¯èŒçãã©ã³ã¹ããååšããŠãããããããçŸä»£ã®é£ç掻ã§ã¯ããªã¡ã¬6ç³»ã®èèªã25察1ãšããå²åã§å€ããªã£ãŠããã
EPA/DHAãœãããžã§ã«1æ¬ã§ãEPA/DHAãªã¡ã¬3èèªé žãåãããŠ300mgæåããããšãã§ããã
è¡æ¶²åžéå€
ã¢ã¹ããªã³
æ¯æ¥ã®ã¢ã¹ããªã³çæ³ã¯ãå¿èçºäœã®æ¢åŸæŽãå åèçŸæ£ïŒã¢ãããŒã æ§åè硬åçãªã©ïŒããŸãã¯å åèçŸæ£ãçºçããå±éºå åãæããæ£è ã®å¿èçºäœã®ãªã¹ã¯ãäœæžããã
ã«ã³ãããããŒãŒ å ã ã¯ãããºã®Lumbricus
rubellusã«ç±æ¥ãããå®å®æ§ã®é«ãç·æº¶é µçŽ 矀ããã®ã¿ã³ãã¯è³ªåè§£é µçŽ ã¯ãäžåœã§é·å¹Žã«ãããç 究ãããåºãå©çšãããŠãããç 究ã«ãããšãã«ã³ãããããŒãŒã¯å¿èè¡ç®¡ç³»ã«æçãªå¹æããããšãããŠããããã¹ãã»ã«ã³ãããããŒãŒã¯ããã®é µçŽ 矀ã®é«æŽ»æ§åã§ãããå¥åº·ãªå¿è¡ç®¡æ©èœã®ãµããŒããšç¶æã®ããã«äœ¿çšããããšãã§ããã
è¡ç®¡ã®å¥åº·
ã¢ã«ã®ãã³
l-ã¢ã«ã®ãã³ã¯ãèãéãªã©ã®ã¿ã³ãã¯è³ªãè±å¯ãªé£åã«å«ãŸããŠããã欧米人ã®1æ¥ã®å¹³åçãªé£äºã«ã¯5gã®l-ã¢ã«ã®ãã³ãå«ãŸããŠãããããã®å€ãã¯èµ€èº«ã®èã®æåã«ãããã®ã§ãããã¬ã€ïŒããªãŒã¯ãäžè¬çã«1æ¥3ïœ6ã°ã©ã ã®ã¢ã«ã®ãã³ãæšå¥šããŠããã
ã³ãªã³
ãã®æ°Žæº¶æ§ãã¿ãã³ã®ãããªå¿ é æ é€çŽ ã¯ãå€ãã®æ€ç©ãåç©ã®èåšã«å«ãŸããŠãããã³ãªã³ã¯ç¥çµäŒéç©è³ªã§ããã¢ã»ãã«ã³ãªã³ã®åé§äœã§ãããèšæ¶ãçèã®å¶åŸ¡ãªã©å€ãã®æ©èœã«é¢äžããŠããã
TMG
ããªã¡ãã«ã°ãªã·ã³ïŒTMGïŒããŸãã¯ãã¿ã€ã³
ãã¢ã·ã¹ãã€ã³ã¬ãã«ãäžããå¿èç ã®ãªã¹ã¯ãäœæžããéåããã©ãŒãã³ã¹ãåäžãããããã ããã³ã¬ã¹ãããŒã«å€ãäžæãããå¯èœæ§ãããã
è³ã®å¥åº·
GABA
GABAã¯ãè³å ã®ç¥çµçŽ°èéã®ã€ã³ãã«ã¹ãé®æããç¥çµäŒéç©è³ªã§ãããGABAã®éãå°ãªããšã以äžã®ããšã«é¢é£ããå¯èœæ§ãããã
äžå®é害ãæ°åé害 ç²çïŒãŠããã) æ ¢æ§çãªçã¿
ç 究è ã¯ãGABAãæ°åãé«ããããç¥çµç³»ãèœã¡çãããŠãªã©ãã¯ã¹ãããå¹æãããã®ã§ã¯ãªãããšèããŠããã
ã°ãªã»ãªã«ãã¹ãã¡ããžã«ã³ãªã³ïŒGlyceryl phosphatidylcholineïŒ
倧è±ãªã©ã®æ€ç©ã«å«ãŸããèèªé žãå解ãããŠã§ããååŠç©è³ªãå»è¬åãšããŠäœ¿çšãããããšãŒãããã§ã¯ã¢ã«ããã€ããŒç ã®æ²»çè¬ãšããŠå»åž«ããåŠæ¹ãããããšãå€ãããã¢ã¡ãªã«ã§ã¯Î±-GPCã¯æ é€è£å©é£åãšããŠã®ã¿è²©å£²ãããŠãããäž»ã«èšæ¶ååäžãç®çãšãã補åã«é åãããŠããã
ã¡ã©ããã³
ã¡ã©ããã³ã¯ãè³ã®æŸæäœã§äœããã倩ç¶ã®ãã«ã¢ã³ã§ãããã¡ã©ããã³ã®ç®çã¯ãè³ãç¡ç ãèµ·åºã®æéãç¥ãã®ãå©ããããšã§ããã
ãã¯ã¹ãã«ãã³
COX-2é»å®³å€ãšããŠã®æ©èœãæã¡ãæ§ã ãªCOX-2é»å®³å€ã®æ¬ ç¹ããªãã«ãããããããäœå šäœã«åºããççãšæŠããµããªã¡ã³ãã
ã±ã«ã»ãã³
ãã®æ€ç©æ§è²çŽ ïŒãã©ããã€ãïŒã¯ãã¿ããã®ãèµ€ã¯ã€ã³ããªã³ãŽãããªãŒé¡ãªã©ãå€ãã®æ€ç©ãé£åã«å«ãŸããŠãããã±ã«ã»ãã³ã¯ãå¿èãè¡ç®¡ã®çç¶ã®æ²»çãããã®äºé²ã«æããã䜿ãããã
ãã¬ãŒã·ã§ã³çæ³ïŒè§£æ¯äœçšïŒ
DMPS
ååŠååç©ãšã¿ã³ãã¯è³ªãè¡æ¶²äžã«æ³šå ¥ããéäžæ¯ãªã©ã®çç¶ãæ²»çããã
EDTA
ééå±ãããã©ã«ãè¡æ¶²äžã«çµåãããå°¿äžã«ææ³ãããããã®éè泚å°ã
æ¶ååšå®
ã¢ã·ããã£ã«ã¹ã»ããã£ããã¯ããªãŠã
è žå /èè žã®å¥åº·ãšè žå šäœã®å¥åº·ããµããŒããã奜ãŸããè žå ãããŒã©ãä¿é²ãããããã€ãªãã£ã¯ã¹
ãã¿ã€ã³HCL
以åããã¿ã€ã³HCLã¯ãèé žåæ³ä¿é²å€ã»æ¶åä¿é²å€ããšããŠåžè²©ãããŠãããä»æ¥ã§ã¯ããã®åãå¹æã®ããã«ãæ é€è£å©é£åãšããŠè²©å£²ãããŠããããŸããäœã¬ãã«ã®ã«ãªãŠã ãè±ç²çãåæ¯ã®æ²»çãèèã®ä¿è·ã®ããã«ã䜿çšãããŠããã
éã®ã¿ã³ãã¯è³ª
å¥åº·ã«æ¬ ãããªãå€äŸ¡äžé£œåèèªé žïŒPUFAïŒã¯ãäœå ã®äžéšã®æ©èœã«å¿ èŠã§ãããç 究調æ»ã«ãããšããªã¡ã¬3èèªé žã¯ãé¢ç¯ãªãŠãããåæ¯ããã€ç ããããADHDãå¿è¡ç®¡çŸæ£ãæ§ã ãªèªå·±å ç«çŸæ£ãªã©ãå¹ åºãçŸæ£ã«å¹æããããšèšãããŠããã
ãã©ã¯ããªãªãŽç³
ç ç³ãããã«ããªãŒãäœãããã代æ¿çå³æãšããŠãã䜿ãããç³è³ªã§ããã
ãªã³ããŠã®æ ¹
é£æ¬²äžæ¯ãæºè ¹æãè žå ã¬ã¹ãäžç¢ãèçãèžãããååãªã©ã®æ¶ååšç³»ã®çç¶ãæ¹åããããŒãã§ãæ ¹ããäœãããããŸããçºç±ããã¹ããªãŒãç³å°¿ç ãé«è¡å§ãªã©ã«ã䜿ããããçèã®çæ£ãé²ããå¯çè«ãæ²»çããæçµãéå§ãã现èãã©ãŒãšããŠãªã³ããŠã䜿ã人ãããã
l-ã°ã«ã¿ãã³
äžç¢ãç¥çµçãªã©ãå»çè¡çºã«ããå¯äœçšã®æ²»çã«ãã䜿ããã倩ç¶ã®ã¢ããé žããŸããè朰çãã¯ããŒã³ç ãªã©ã®æ²»çã«ãçšããããæ°åãæŽããå¹æãããã
N-ã¢ã»ãã«-D-ã°ã«ã³ãµãã³ïŒN-acetyl-D-glucosamineïŒããã®ååŠç©è³ªã¯ãå€åœ¢æ§é¢ç¯çãã朰çæ§å€§è žçãã¯ããŒã³ç ãªã©ã®ççæ§è žçŸæ£ïŒIBDïŒã®ããã«æåããããããã«ãN-ã¢ã»ãã«ã°ã«ã³ãµãã³ãèã«å¡ããšãå 霢ãæ¥çŒãã«ããé»ãã¿ãæããããšãã§ããã
ãããŒãã³ã
ãåç¥ãªãã£ããããããªããããããŒãã³ããªã€ã«ã¯ãã¬ã¹ãèšæºæãæ¶åäžè¯ãçã¿ãäžæŽèãªã©ã®éææ§è žçå矀ïŒIBSïŒã®çç¶ã«å¯ŸããŠãæãæšå¥šãããŠããèªç¶çæ³ã®1ã€ã§ããã
ããã·ã³
èã®äžã§äœãããé µçŽ ã§ãã¿ã³ãã¯è³ªãããå°ããªããããã«å解ããé£ã¹ç©ã«å«ãŸããã¿ã³ãã¯è³ªã®æ¶åãå©ããã
ç®ã®å¥åº·
ãã«ããªãŒãšãã¹
å€éèŠåããµããŒããããšå ±åãããŠããããªãŒé¡ã®ãšãã¹ã ããç§åŠçãªæ ¹æ ã¯ãªãã
ã«ãã€ã³
ãããã³ãªãŒãã»ãããèãã±ãŒã«ããšããããããããŠã€ãã«ãŒããã¶ã©ããã«ããã£ããªã¬ã³ãžãžã¥ãŒã¹ããºãããŒããã«ããã£ãªã©ã«å«ãŸããã«ãããã€ãç³»ãã¿ãã³ã§ãããã«ãã€ã³ã¯ãå 霢é»æå€æ§çãçœå éã網èè²çŽ å€æ§çãªã©ã®ç®ã®ç æ°ãäºé²ããããã«ããæåãããã
ãã¹ãã¹ããã³ããŒã¹ã¿ãŒ
DHEA
å¯è ããåæ³ããããã«ã¢ã³ã§ãæ§æ¬²å¢é²ãèåé²æ¢ã«å¹æããããšèšãããŠããã
ã¯ãªã·ã³
æ€ç©ã«å«ãŸãããã©ããã€ãã§ãããã£ãŒãã«ãäžå®ç¥çµçãççãç颚ãHIV/AIDSãåèµ·äžå šïŒEDïŒãè±æ¯ãçäºé²ãªã©ã«çšããããã
ãžã³ãžã£ãŒ
ã©ããã䜿ã£ãããã€ãã®ç 究ã§ãçå§ããã¹ãã¹ããã³ã®ã¬ãã«ãšæ§æ©èœã«è¯ã圱é¿ãäžããããšãããã£ããããç 究ã§ã¯ãçå§ãäžããããã©ããã¯ãã¹ãã¹ããã³ã¬ãã«ã2åã«ãªã£ãã
ã€ã³ããŒã«-3-ã«ã«ãããŒã«
éèã«ããå«ãŸããç©è³ªã§ããã¹ãã¹ããã³ã®å¢å ãããäºé²ã«äœ¿çšãããã
ããã«
ãã¹ãã¹ããã³ãå¢ããæ€ç©ã§ãSHBGïŒSex Hormone Binding GlobulinïŒãé»å®³ããããšã§ããã¹ãã¹ããã³ãäœå ã§ããçç©åŠçã«å©çšå¯èœã«ãªãããåãããã
PtC
ãã¹ãã¹ããã³ïŒåŠæ¹ç®ïŒ
AGEsãæå¶ãã
泚ïŒAGEsïŒadvanced
glycated end productsïŒãšã¯ãç³ãã¿ã³ãã¯è³ªååãªã©ã®çŽ°èæ§æèŠçŽ ãç Žå£ããé«ååã®æå·ãåŒãèµ·ããããšã§åœ¢æããããã²ããµã€ãšã³ãã£ã¹ããšåŒã°ããã¢ã³ããšã€ãžã³ã°ç 究è ã¯ãå 霢ã«ãã£ãŠäœå ã«èç©ãããAGEsãããŸããŸãªç æ°ã«ã€ãªãããšææããŠããã
ã¢ã«ãã¡ãªãé ž
ãªãé žã¯ãäœå ã«ååšããåæ€ç©ã«ãã£ãŠåæããã倩ç¶ã®é žã§ããããããŠç³ãäœã®ãçæãã«å€ããã®ãå¹æçã«ãµããŒãããã
ã«ã«ãã·ã³
çèãåããŠãããšãã«éäžçã«åã倩ç¶ã®çæã¢ããé žã§ãããã«ã«ãã·ã³ã¯ãèåãé ãããããç¥çµé害ãç®ã®é害ãè èã®åé¡ãªã©ãç³å°¿ç ã«ç±æ¥ããå䜵çã®æ²»çã«çšããããã
n-ã¢ã»ãã«-ã«ã«ããã³
ã¢ã»ãã«-L-ã«ã«ããã³ã¯ãäœå ã§èªç¶ã«çæãããã¢ããé žïŒã¿ã³ãã¯è³ªã®æ§æèŠçŽ ïŒã§ãããäœå ã§ã®ãšãã«ã®ãŒçæãå©ãããå¿èãè³ã®æ©èœãçèã®åãããã®ä»å€ãã®äœã®ããã»ã¹ã«éèŠãªåœ¹å²ãæãããŠããã
ãã¢ã·ã¹ãã€ã³ã¬ãã«ãäžãã
ãã¿ãã³B-6
ããªããã·ã³ããšããŠãç¥ããããã¿ãã³B矀ã®äžéšã§ããB-6ã¯ãå¥åº·çãªä»£è¬ã®ç¶æãç®èã®å¥åº·ãç®ã®å¥åº·ãç¥çµæ©èœãèæ©èœããšãã«ã®ãŒã®å¢åŒ·ãªã©ã«åœ¹ç«ã€ããšã§æãããç¥ãããŠããã
èé ž
èé žã¯ãæ°Žã«æº¶ãããã¿ãã³B-9ã®äžçš®ã§ãèµ€è¡çã®çæã«äžå¯æ¬ ãªã»ãã现èåè£ãæé·ãå©ããè³ã®å¥åº·ãDNAã®ä¿®åŸ©ãå 霢æ§é£èŽã®äºé²ã«ã圹ç«ã€ã
ã¹ãã¬ã¹
β-ã·ãã¹ãããŒã«
β-ã·ãã¹ãããŒã«ã¯ãæç©ãéèããããé¡ã«å«ãŸããççæ§ãµã€ãã«ã€ã³ã®ç£çãå¶åŸ¡ããããšã«ãããå ç«æ©èœãççãçã¿ã®ã¬ãã«ã調æŽããããšãç¥ãããŠããã
ç·è¶ãšãã¹
ç·è¶ãšãã¹ã¯ã现èã®æå·ã軜æžããçèã®ç²åŽãé ãããããšã§ãéåããã©ãŒãã³ã¹ãåäžãããå埩åãé«ãããšèããããŠããã
L-ãã¢ãã³
ç·è¶ã«å«ãŸããã¢ããé žã§ããL-ãã¢ãã³ã¯ãäžå®çãé«è¡å§ãã¢ã«ããã€ããŒç ã®æ²»çãæããå€ã®å¹æãé«ããããã«ãã䜿ãããã
ãã¹ãã¡ããžã«ã»ãªã³ïŒPhosphatidylserineïŒããã®ååŠç©è³ªã¯ãäžè¬çã«ãã£ããã倧è±ãã補é ããã现èã®æ©èœãç¶æããããã«äœ¿çšãããã粟ç¥æ©èœã®æ¹åã«ããã䜿ãããã
2åç³å°¿ç
ã¯ãã ã®ããšãâäžäŸ¡ã¯ãã
âã¯å¿ é 埮éå çŽ ã§ãååç©ã圢æããŠã€ã³ã¹ãªã³ã®å¹æãé«ããã°ã«ã³ãŒã¹ã¬ãã«ãäœäžãããã
ã®ã ããã»ã·ã«ãã¹ãã©ïŒGymnema)
sylvestraïŒãã€ã³ããã¢ããªã«åç£ã®æšè³ªç³»ã®ç»ææ§äœæšã§ãããèã¯ç³å°¿ç ã®æ²»çãæžéãªã©ã«çšããããã
ã¡ããã«ãã³ïŒRayã®2åç³å°¿ç ã«åŠæ¹ïŒ
ç³å°¿ç ã®æ²»çè¬ãšããŠåŠæ¹ãããŠããããå°éã®æçšã§çã®ãªã¹ã¯ãæžå°ãããå¹æãããã
ã³ã¬ã¹ãããŒã«
ã°ã¬ãŒããã«ãŒãããŠããŒ
ã°ã¬ãŒããã«ãŒãã¯ãäœéæžå°ãšã³ã¬ã¹ãããŒã«å€ã®äœäžããµããŒãããããšãå€ãããç¥ãããŠããã
GuggulipidïŒå¥åGugulipidãŸãã¯GuggulïŒ
ç®èã®å¥åº·ç¶æãå¥åº·çãªäœéãæ¶ååšç³»ãå¥åº·çãªã³ã¬ã¹ãããŒã«å€ã®ç¶æã«ãã䜿ãããæ€ç©ã§ããã
ã¬ã·ãã³
ã¬ã·ãã³ã¯ãäœå ã®çŽ°èã«äžå¯æ¬ ãªèèªã§ããã倧è±ãåµé»ãªã©ãå€ãã®é£åã«å«ãŸããŠãããã³ã¬ã¹ãããŒã«ã®ãµããŒãã ãã§ãªããèªç¥çãã¢ã«ããã€ããŒç ãªã©ã®èšæ¶é害ã®æ²»çã«ã䜿çšãããŠããããŸããèå¢çŸæ£ãèèçŸæ£ãããçš®ã®ãã€ç ãäžå®ç¥çµçã湿ç¹ãšåŒã°ããç®èçŸæ£ã®æ²»çã«ã䜿çšãããŠããã
ãªãŒããã©ã³
ãªãŒããã©ã³ã¯ãäœé管çãã³ã¬ã¹ãããŒã«ã®ãµããŒããå¿èã®å¥åº·ãããã«ã¯ç³å°¿ç ã®ç®¡çã®ããã«æåãããã
æ€ç©ã¹ãããŒã«
æ€ç©ã¹ãããŒã«ã¯ãã¹ã¿ããŒã«ãšäžŠãã§ãå€ãã®ç©ç©ãéèãæç©ãããããçš®åãªã©ã«èªç¶ã«å«ãŸããç©è³ªã§ããã匷åãªã³ã¬ã¹ãããŒã«äœäžäœçšãããã
ããªã³ãµããŒã«
ããªã³ãµããŒã«ã¯ããµããŠãããå°éºŠãªã©ã®æ€ç©ããæœåºãããããšãå€ãååŠç©è³ªã§ãããã³ã¬ã¹ãããŒã«ãä¿é²ããèã®çã¿ã軜æžããç®çã§æããã䜿ãããã
ãµã€ãªãŠã
ãµã€ãªãŠã ãšã¯ãæ€ç©ã®çš®åã®æ®»ããäœãããç¹ç¶ã®äžçš®ã§ãããã€ã¹ãã°ãŒã©ãšããååã§åŒã°ããããšããããã³ã¬ã¹ãããŒã«ã®ãµããŒãã«å ããŠãèã®çã¿ã«ã䜿çšãããã
ã¢ãã«ãã¹ã¿ãã³
LDLã³ã¬ã¹ãããŒã«ãäžããããã®åŠæ¹è¬
ãã¿ãã³B-3
ãã€ã¢ã·ã³ããšãåŒã°ãããã¿ãã³ã§ãHDLã³ã¬ã¹ãããŒã«ãäžããããã«æåãããã
ãã¿ãã³ / æ é€çŽ
ã³ãšã³ã¶ã€ã Q10
ãã®åŒ·åãªå€©ç¶æé žåç©è³ªã¯äœå ã§åæãããå€ãã®é£åã«å«ãŸããŠããã
ãã€ãªãŒãã«ããã¿ãã³
è€æ°ã®ãã¿ãã³ãšããã©ã«ãå«ãã
ããªãããµãŒã«-5-ãªã³é ž
ããªãããµãŒã«ãªã³é žå¡©ã¯ã掻æ§åãã¿ãã³B6ã§ãããå€ãã®ããªãããµãŒã«ãªã³é žå¡©ïŒPLPïŒäŸåæ§é µçŽ ã®è£é µçŽ ã§ããã
ãã¿ãã³B-12ã®æ³šå°ïŒã¡ã¬ããŒãºïŒ
ãã®è¶ 倧éã®B-12ã¯ãäžè¬çã«æ¯çŽ ãç¥çµçŸæ£ã«å¯Ÿããæ²»çãšããŠããããã¯B-12ã®äœå 貯èµéãè£å ããéã«æçšãããã
L-ã«ã«ããã³
ãã®ã¢ããé žã¯ãå¿èã«é¢é£ããèžã®çã¿ããã£è¡æ§å¿äžå šïŒCHFïŒãå¿èç ã®å䜵çãå¿çæ¢å¡ãè¡è¡é害ã«ããèã®çã¿ãé«ã³ã¬ã¹ãããŒã«ãªã©ãå¿èãè¡ç®¡ã®çç¶ã«äœ¿çšãããã
ãã¿ãã³D
ãã¿ãã³Dã¯ãã«ã«ã·ãŠã ã®åžåãå©ããæ é€çŽ ã§ãããã«ã«ã·ãŠã ãšãã¿ãã³Dã¯å ±ã«ãå¥åº·ãªéªšãšæ¯ãç¶æããããã«åããããŸãããã¿ãã³Dã¯ãçèãç¥çµãå ç«ç³»ãæ£åžžã«åãã®ãå©ãããæè¿ã®ç 究ã§ã¯ããã¿ãã³Dãå€çºæ§ç¡¬åçãäžéšã®çãªã©ã®ç æ°ã®ãªã¹ã¯ãäžããããšã«é¢é£ããŠããå¯èœæ§ã瀺ãããŠããã
å¥åº·å šè¬
ãªã³ãã³
æç©ãéèã«èµ€ãè²ãäžãã倩ç¶ç±æ¥ã®ååŠç©è³ªã§ãããã«ãããã€ããšåŒã°ããæ°å€ãã®è²çŽ ã®1ã€ã§ããããªã³ãã³ã¯ãå¿èç ãã¢ãããŒã æ§åè硬åçãããã³åç«è ºçãä¹³çãèºçãèè±çãåµå·£çãå€§è žçãèµèçã®äºé²ã®ããã«æåãããããŸããåå®®ããã®äž»ãªåå ã§ããHPVææçã®æ²»çã«ã䜿çšãããŠããã
N-ã¢ã»ãã«-L-ã·ã¹ãã€ã³ïŒN-acetyl-L-cysteineïŒã颚éªãã€ã³ãã«ãšã³ã¶ã«äŒŽãå³ãåããç°ãªã©ã®çç¶ã«å¹æãããã
ã·ãªããªã³ïŒãã©ããã€ãïŒ
é žåã¹ãã¬ã¹ã¯ç®èã®çºçã®éèŠãªèŠçŽ ã®äžã€ã§ãããããç®èçãäºé²ããããã«éæ¯æ§ã®åŒ·ãæé žåç©è³ªãç¹å®ããããŸããèèã®å¥åº·ã«ã圹ç«ã€ã
ãããŠçš®åãšãã¹
ãããŠçš®åãšãã¹ãå€ãã®å¿è¡ç®¡çŸæ£ã«å¹æãããããšã瀺åãã蚌æ ãããããããŠçš®åãšãã¹ã¯ãäžçš®ã®è¡è¡äžè¯ïŒæ ¢æ§éèäžå šïŒãé«ã³ã¬ã¹ãããŒã«ã«å¹æããããšèšãããŠããããŸããã°ã¬ãŒãã·ãŒããšãã¹ã¯ãæªæã«ããè «ãã軜æžããç³å°¿ç ã«é¢é£ããçŒç ã«ãå¹æããããšèšãããŠããã
ãšããã»ã¢
ã€ã³ãã«ãšã³ã¶ã颚éªã®äºé²ã«ãã䜿ãããããŒãã§ããã
ã«ãã«ã
ã«ãã«ãã¯æ é€äŸ¡ãé«ããäœã«ããªãŒã®æ€ç©ã§ããã1ãªã³ã¹ïŒ28ã°ã©ã ïŒã®ãã³ãã¯ã«ã¯ä»¥äžãå«ãŸããã
ãã³ã¬ã³
RDAã®23
ãã¿ãã³B6
RDAã®17
ãã¿ãã³C
RDAã®15
ã»ã¬ã³
RDAã®6
é£ç©ç¹ç¶
0.6ã°ã©ã ããŸãšãŸã£ãéã®ã«ã«ã·ãŠã ãé ãã«ãªãŠã ããªã³ãéããã¿ãã³B1
æ§ã ãªããŒã
ãã®ä»ãæ§ã ãªããŒããã¬ã€ã®é£äºã«åãå ¥ããå¥åº·å šè¬ããµããŒãããŠããã
ãã®ä»
ãã³ãã»ãã³
è³ã®è¡æµãè¯ãããèšæ¶åãé«ããã¢ã«ããã€ããŒç ãäºé²ããããã«äœ¿çšãããããŸããå 霢ã«äŒŽãåŠç¿èœåãèšæ¶åãæ å ±åŠçèœåã®äœäžã«ã䜿çšãããã
ã¢ã«ã«ãªã€ãªã³æ°Ž
ã¢ã«ã«ãªã€ãªã³æ°Žãšã¯ãæ°Žéæ°Žãããé žæ§åºŠãäœãæ°Žã®ããšã§ãã«ã«ã·ãŠã ãã·ãªã«ãã«ãªãŠã ãçé žæ°ŽçŽ å¡©ããã°ãã·ãŠã ãªã©ã®ã¢ã«ã«ãªæ§ååç©ãè±å¯ã«å«ãŸããŠããã
ã°ã«ã¿ããªã³
ã°ã«ã¿ããªã³ã¯ãèèã§èªç¶ã«çæãããç©è³ªã ããæç©ãèãéèã«ãå«ãŸããŠãããçœå éãç·å éã®æ²»çãèåé²æ¢ãã¢ã«ã³ãŒã«äŸåçã®æ²»çãäºé²ãåæ¯ãçãå¿èç ãèçãèèç ãäœã®é²åŸ¡ã·ã¹ãã ã匱ããç æ°ãèšæ¶åªå€±ãã¢ã«ããã€ããŒç ãå€åœ¢æ§é¢ç¯çãããŒãã³ãœã³ç ãªã©ã®æ²»çã®ããã«ã°ã«ã¿ããªã³ãæåãã人ãããã
ãã³ãã³ã¢ãããªãã·ãïŒNRïŒ
NRã¯ããã¿ãã³B3ã®ãŠããŒã¯ãªåœ¢æ ã§ãâNADåé§äœ âã§ãããããã³ã³ããªã¢ïŒå现èã®ååæºïŒã®å¥åº·ç¶æ ãå¹æçã«åäžããããCoQ10ãPQQãšåæ§ã«ããã³ãã³ã¢ãããªãã·ãã¯èº«äœæ©èœãšèªç¥æ©èœã®äž¡æ¹ãé«ããå¹æãããã
ãšã¯ãããããã ãã®éãæåããããšã«æµæããã人ãããã ãããå 霢ã«å¯Ÿæããããã«ã©ã€ãã¹ã¿ã€ã«ãå€ããã«ã¯ãçžåœãªèŠæãå¿ èŠã§ãããã¬ã€ã®å Žåã¯ãæ è¡ãè¬æŒãä»äºãªã©ã§å€å¿ãªãããå³ããäœå¶ã§èšãã§ããã
å¿ãããŠãããµããªã¡ã³ãã«ã©ããŸã§æãåºããã¯å¥ã«ããŠãé·çãããããã«ã¯ä»æ¥ããã§ãå®è¡ã§ããããšãç¥ã£ãŠããããšã倧åã§ããã
ç¶ããŠãYOUTUBEãã§ãã
Dr.Luke's Kingdom Fellowship:ãã³ã°ãã ã»ãã§ããŒã·ãã
ãã£ã³ãã«ç»é²è æ° 1220人
ãããªãã¯ã¹ãšã¯äœãïŒâ
facebook friend - Dr.Luke
3,496 åèŠèŽ 2016/12/03
Dr.Luke's Kingdom Fellowship Bible Message
ã¿ã€ãã«ïŒãWhat Is Matrix?ã
ã»Kingdom Fellowship Podcastâhttp://podcast.kingdomfellowship.com
ã»Kingdom Fellowship Ministriesâhttp://www.kingdomfellowship.com
fafatete tetafw
ãã£ã³ãã«ç»é²è æ° 777人
äžèäžæ»ãžã®ææŠ
10,223 åèŠèŽ 2012/07/12
ãæäŒãã«å¯Ÿããç©æ¥µçãªåãçµã¿ããã
ç±³åéšãããã¹ãé£çã声æ
2019幎5æ2æ¥12æ48å
ã¯ãªã¹ãã£ã³ãã¥ã㣠- Twitterçžäºãã©ããŒ
ã¬ã€ã»ã«ãŒãã¯ã€ã«ã
æã£ãŠãããµããªã¡ã³ããšãã®çç±ã¯ïŒ
2022.02.06
Alzhacker/ã¢ã«ãããã«ãŒ.
0ã³ã¡ã³ã